scholarly article | Q13442814 |
P50 | author | Michael Hsiao | Q46884406 |
P2093 | author name string | Y Eugene Chin | |
P-C Yang | |||
R-H Chen | |||
M-H Yang | |||
C-C Chang | |||
Y-M Jeng | |||
C-Y Chu | |||
S-T Chen | |||
S-K Lin | |||
M-L Kuo | |||
S-H Pan | |||
B-R Lin | |||
T-C Lai | |||
P2860 | cites work | Recovery of anoikis in Src-transformed cells and human breast carcinoma cells by restoration of the SIRP α1/SHP-2 signaling system. | Q53281866 |
Expression of connective tissue growth factor is in agreement with the expression of VEGF, VEGF-C, -D and associated with shorter survival in gastric cancer. | Q53328305 | ||
DAP kinase links the control of apoptosis to metastasis | Q59083516 | ||
Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor | Q71703153 | ||
Connective tissue growth factor gene expression alters tumor progression in esophageal cancer | Q77811241 | ||
Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis | Q80579946 | ||
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains | Q24307661 | ||
Functions and mechanisms of action of CCN matricellular proteins | Q24642303 | ||
Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation | Q24653688 | ||
A tale of two Cbls: interplay of c-Cbl and Cbl-b in epidermal growth factor receptor downregulation | Q24655468 | ||
PID: the Pathway Interaction Database | Q24656193 | ||
Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization | Q27650259 | ||
Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis | Q28252815 | ||
Anoikis: cancer and the homeless cell | Q28278884 | ||
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB | Q28589970 | ||
Activated Cdc42 Sequesters c-Cbl and Prevents EGF Receptor Degradation | Q28609930 | ||
A multigenic program mediating breast cancer metastasis to bone | Q29614308 | ||
Cool-1 functions as an essential regulatory node for EGF receptor- and Src-mediated cell growth | Q33253028 | ||
Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized | Q33779882 | ||
Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage. | Q34169176 | ||
Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis | Q34302672 | ||
Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance | Q36076333 | ||
The tumor suppressor DAP-kinase links cell adhesion and cytoskeleton reorganization to cell death regulation | Q36386122 | ||
Metastasis: recent discoveries and novel treatment strategies | Q36407511 | ||
The MET receptor tyrosine kinase in invasion and metastasis | Q36868644 | ||
CCN2, the connective tissue growth factor | Q37031962 | ||
Connective tissue growth factor (CTGF) and cancer progression | Q37214721 | ||
The epidermal growth factor receptor ligands at a glance | Q37324458 | ||
Src kinases as therapeutic targets for cancer | Q37604891 | ||
Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond | Q38309484 | ||
SRC directly phosphorylates Bif-1 and prevents its interaction with Bax and the initiation of anoikis | Q39627698 | ||
The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR. | Q40084671 | ||
Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. | Q40474669 | ||
Epidermal Growth Factor Receptor Activation Differentially Regulates Claudin Expression and Enhances Transepithelial Resistance in Madin-Darby Canine Kidney Cells | Q40620861 | ||
Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas | Q44418604 | ||
Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis | Q44502162 | ||
P2507 | corrigendum / erratum | Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation | Q91304395 |
P433 | issue | 3 | |
P921 | main subject | cancer metastasis | Q120912394 |
P304 | page(s) | 443-455 | |
P577 | publication date | 2012-11-23 | |
P1433 | published in | Cell Death & Differentiation | Q2943974 |
P1476 | title | CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation | |
P478 | volume | 20 |
Q37321763 | CCN family of proteins: critical modulators of the tumor cell microenvironment. |
Q55035206 | Can insulin-like growth factor 1 (IGF-1), IGF-1 receptor connective tissue growth factor and Ki-67 labelling index have a prognostic role in pulmonary carcinoids? |
Q36916437 | DANGER is involved in high glucose-induced radioresistance through inhibiting DAPK-mediated anoikis in non-small cell lung cancer |
Q91473440 | DAPK1 loss triggers tumor invasion in colorectal tumor cells |
Q38212057 | Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer |
Q92756758 | ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation |
Q48236059 | Induction of Cbl-dependent epidermal growth factor receptor degradation in Ling Zhi-8 suppressed lung cancer. |
Q33735255 | Input of microenvironmental regulation on colorectal cancer: role of the CCN family |
Q58712169 | NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR |
Q35955331 | Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer. |
Q46433404 | Regulation of anoikis resistance by NADPH oxidase 4 and epidermal growth factor receptor |
Q37362819 | Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo |
Search more.